DV Biomed Co., Ltd. (TPEX:6539)
Taiwan · Delayed Price · Currency is TWD 36.20
0.00 (0.00%)
Nov 10, 2026, 9:00 AM CST
DV Biomed Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 881 | 1,437 | 1,284 | 2,914 | 3,287 | 3,479 | |
Market Cap Growth | -35.36% | 11.93% | -55.96% | -11.33% | -5.52% | -17.04% |
Enterprise Value | 566 | 1,167 | 1,041 | 2,859 | 2,951 | 2,981 |
Last Close Price | 36.20 | 56.77 | 49.57 | 109.52 | 113.41 | 109.10 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.51 | 185.68 | 14.41 | 17.89 | 11.69 | 11.42 |
PS Ratio | 1.11 | 1.81 | 2.24 | 4.71 | 1.76 | 1.90 |
PB Ratio | 1.60 | 2.83 | 2.40 | 6.12 | 2.87 | 2.95 |
P/TBV Ratio | 1.61 | 2.85 | 2.42 | 2.79 | 2.88 | 2.96 |
P/FCF Ratio | 17.49 | 48.95 | 10.92 | 43.44 | 8.18 | 7.56 |
P/OCF Ratio | 12.55 | 24.99 | 10.78 | 41.86 | 6.29 | 6.66 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.71 | 1.47 | 1.82 | 4.62 | 1.58 | 1.63 |
EV/EBITDA Ratio | 5.38 | 36.46 | 9.13 | 17.82 | 6.29 | 5.49 |
EV/EBIT Ratio | 7.62 | 78.58 | 9.50 | 19.19 | 7.63 | 7.12 |
EV/FCF Ratio | 11.22 | 39.77 | 8.86 | 42.61 | 7.34 | 6.47 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.07 | 0.09 | 0.25 | 0.01 | 0.41 | 0.19 |
Debt / EBITDA Ratio | 0.35 | 0.93 | 1.03 | 0.02 | 0.82 | 0.38 |
Debt / FCF Ratio | 0.73 | 1.55 | 1.12 | 0.06 | 1.16 | 0.49 |
Net Debt / Equity Ratio | -0.57 | -0.55 | -0.47 | -0.57 | -0.10 | -0.32 |
Net Debt / EBITDA Ratio | -3.64 | -8.63 | -2.18 | -1.70 | -0.25 | -0.69 |
Net Debt / FCF Ratio | -6.27 | -9.41 | -2.12 | -4.06 | -0.29 | -0.82 |
Asset Turnover | 1.15 | 1.09 | 0.84 | 0.47 | 0.95 | 0.99 |
Inventory Turnover | 1.87 | 2.41 | 2.11 | 1.35 | 6.22 | 6.61 |
Quick Ratio | 2.75 | 2.62 | 3.19 | 3.15 | 1.75 | 1.86 |
Current Ratio | 3.76 | 3.55 | 4.01 | 3.87 | 2.09 | 2.20 |
Return on Equity (ROE) | 14.97% | 1.55% | 20.31% | 16.15% | 24.87% | 25.57% |
Return on Assets (ROA) | 6.71% | 1.28% | 9.98% | 7.03% | 12.37% | 14.20% |
Return on Invested Capital (ROIC) | 26.09% | 4.60% | 36.50% | 19.67% | 33.50% | 37.52% |
Return on Capital Employed (ROCE) | 12.90% | 2.80% | 17.20% | 31.00% | 24.60% | 30.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.69% | 0.54% | 6.94% | 5.59% | 8.56% | 8.76% |
FCF Yield | 5.72% | 2.04% | 9.16% | 2.30% | 12.23% | 13.23% |
Dividend Yield | 5.53% | 1.02% | 4.50% | 6.16% | 9.64% | 7.50% |
Payout Ratio | 50.87% | 480.08% | 90.29% | 183.51% | 109.03% | 107.01% |
Buyback Yield / Dilution | -0.02% | 0.09% | 0.18% | 0.17% | 0.76% | 0.81% |
Total Shareholder Return | 5.51% | 1.10% | 4.68% | 6.32% | 10.40% | 8.30% |